Andreas Strüngmann: Difference between revisions
Content deleted Content added
m Cleanup at the vital dates |
|||
| Line 1: | Line 1: | ||
'''Andreas Strüngmann''' (1950 |
'''Andreas Strüngmann''' (born 1950) was born in Germany and founded [[generic drug]] maker [[Hexal|Hexal AG]] ($1.6 billion sales during 2004) in 1986. They eventually built it into Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. [[Eon Labs]] to [[Novartis]] for $7.5 billion, making Sandoz the largest generic-drug company in the world. |
||
He currently has residences in [[Tegernsee]], Germany, Europe and Russia and is married with two children. At age 56 he isn't quite ready to retire so he accepted an executive position at [[Sandoz]], a generics division of Novartis. |
He currently has residences in [[Tegernsee]], Germany, Europe and Russia and is married with two children. At age 56 he isn't quite ready to retire so he accepted an executive position at [[Sandoz]], a generics division of Novartis. |
||
Revision as of 00:33, 13 February 2009
Andreas Strüngmann (born 1950) was born in Germany and founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. They eventually built it into Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion, making Sandoz the largest generic-drug company in the world.
He currently has residences in Tegernsee, Germany, Europe and Russia and is married with two children. At age 56 he isn't quite ready to retire so he accepted an executive position at Sandoz, a generics division of Novartis.
See also
External links
 | This German business-related biographical article is a stub. You can help Wikipedia by expanding it. |